2019
DOI: 10.1176/appi.ajp.2018.18070857
|View full text |Cite
|
Sign up to set email alerts
|

Interrogating the Genetic Determinants of Tourette’s Syndrome and Other Tic Disorders Through Genome-Wide Association Studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

8
178
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
3

Relationship

3
5

Authors

Journals

citations
Cited by 249 publications
(187 citation statements)
references
References 30 publications
8
178
0
1
Order By: Relevance
“…In total, 4,232 cases and 8,283 ancestry-matched controls were used for the analysis, which resulted in 8,868,895 variants overlapping in the meta-analysis. These summary statistics correspond to the GWAS carried out by Yu et al (17), without samples from the Tic Genetic Consortium.…”
Section: Data Sourcesmentioning
confidence: 69%
See 1 more Smart Citation
“…In total, 4,232 cases and 8,283 ancestry-matched controls were used for the analysis, which resulted in 8,868,895 variants overlapping in the meta-analysis. These summary statistics correspond to the GWAS carried out by Yu et al (17), without samples from the Tic Genetic Consortium.…”
Section: Data Sourcesmentioning
confidence: 69%
“…Over the past few years, twelve genome-wide significant loci have been identified for ADHD (13), and five genome-wide significant loci were described for ASD (14,15). For OCD no genome-wide significant loci have been detected to date (16), while one genome-wide significant locus was recently reported for TS (17).…”
Section: Introductionmentioning
confidence: 99%
“…Genomic evidence reinforces this trans-diagnostic paradigm, facilitated by the GWAS now available for a number of psychiatric disorders in addition to schizophrenia (8-14). Linkage disequilibrium (LD) score regression has demonstrated that schizophrenia displays positive genomic correlation with several psychiatric phenotypes (15), with the most statistically significant relationship observed with bipolar disorder (BIP).…”
Section: Introductionmentioning
confidence: 85%
“…The largest European ancestry GWAS with full genome-wide summary statistics available was obtained for schizophrenia (N = 105318, Pardiñas et al (1)) and seven other psychiatric disorders. The other disorders and their respective GWAS were as follows: bipolar disorder (BIP, N = 51710) (8), attention-deficit/hyperactivity disorder (ADHD, N = 53293 [European subset]) (9), major depressive disorder (MDD, N=173005) [excluding the 23andMe cohorts for which full summary statistics are not publicly available]) (10), obsessive compulsive disorder (OCD, N = 9725) (11), eating disorder (ED, N=14477) (12), autism spectrum disorder (ASD, N=46351) (13), and Tourette’s Syndrome (TS, N=14307) (14). Schizophrenia summary statistics were downloaded from the Walters group data repository (https://walters.psycm.cf.ac.uk/), whilst the other seven summary statistics were obtained from the website of the psychiatric genomics consortium (PGC, https://www.med.unc.edu/pgc/results-and-downloads/).…”
Section: Methodsmentioning
confidence: 99%
“…We next focused on a subset of phenotypes for which diagnostic heterogeneity 374 information exists (ADHD, 43 anorexia nervosa, 44 autism spectrum disorder, 45 bipolar disorder, 46 375 major depressive disorder, 47 schizophrenia, 48 anxiety, 49 and Tourette syndrome; 38 Figure 4 and 376 Table S1). With these phenotypes we tested whether diagnostic information such as number of 377 diagnostic combinations and total symptoms contribute to risk locus effect size distribution 378 descriptive statistics.…”
Section: Correlates Of Effect Size Distribution 303mentioning
confidence: 99%